Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
VEGF-stimulating compounds can, in principle, support the vascularization of existing tumors or accelerate the growth of pre-malignant lesions
Knowing that 1 ml equals 1,000 mcg is critical
Thymosin Beta-4 has been studied in Phase II clinical trials for corneal wound healing, where it showed a 59% reduction in corneal staining compared to placebo
The administration of BPC-157 resulted in a marked reduction of these lesions, suggesting its protective role against NSAID-induced organ damage
US$ 26.81
US$ 26.89
US$ 27.58
US$ 24.86
